VZVC

ActiveVenture Capital

Website LinkedIn

Updated: Jan 22, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Aug 1, 2025	Eight Sleep	$100.0M Series D	—	8090 Industries, Afore Capital, Array Ventures, AV8 Ventures, C2 Investment, Felicis Ventures, FirstHand Alliance, Founders Fund, Greycroft, Harrison Metal, Investo, Lux Capital, M12, Marlinspike, NFX, Plug & Play Ventures, RX3 Growth Partners, True Ventures, UpHonest Capital, Xfund, Y Combinator, Eric Futoran, Patrick S. Chung, Ron Pragides, Steve Norall
Jan 1, 2025	Eleos Health	$60.0M Series C	—	Alex, Alpha Edison, Bond, Drive Capital, Eight Roads Ventures, Ensemble VC, F-Prime Capital Partners, ‎GreatPoint Ventures, Hamilton Lane, Highbury Group, Erel Margalit, Yoav Tzruya, Maccabee Ventures, Menlo Ventures, Thylacine Capital, Uprising, Anne Wojcicki
Jan 1, 2025	Justpoint	$45.0M Series A	—	Lightbank, Right Side Capital Management, 01 Advisors, 9Yards Capital, AAF Management Ltd., Afore Capital, AirAngels, Akshay Kothari, Ali Moiz, Andreessen Horowitz, Antiportfolio Ventures, Backed VC, Basecamp Fund, Basecase Capital, Bradley Horowitz, Brainchild, Brendan O'Driscoll, Chris Smoak, CrunchFund, Divergent Capital, Evan Cheng, Factorial, Flybridge Capital Partners, Founder Collective, George Burke, Hoxton Ventures, Incisive Ventures, KW Angel Fund, LGF, Long Journey Ventures, Mario Gabriele, Matteo Franceschetti, Matthew Dellavedova, Moshe Lifschitz, Pioneer Square Labs, Scott Banister, Scott Belsky, Shrug Capital, Stellation Capital, Supernode Ventures, Symbolic Capital, Todd and Rahul's Angel Fund, Uncork Capital, Vivek Garipalli, Wave Capital, Weekend Fund, What If Ventures
Jan 1, 2025	VideaHealth	$40.0M Series B	—	Andreessen Horowitz, Lux Capital, Pillar VC, Sierra Ventures, Sonder Capital, Spark Capital, Threshold Ventures
Aug 1, 2024	Levels	$10.0M Series A	—	01 Advisors, AAF Management Ltd., AirAngels, Andreessen Horowitz, Backed VC, Basecamp Fund, Brainchild, CrunchFund, Founder Collective, Frst, Highbury Group, IDInvest Partners, Incisive Ventures, Khosla Ventures, KW Angel Fund, Long Journey Ventures, Pioneer Square Labs, Redpoint Ventures, Shrug Capital, Stellar Capital, Supernode Ventures, Todd and Rahul's Angel Fund, Wave Capital, What If Ventures, Bradley Horowitz, Brendan O'Driscoll, Mario Gabriele, Matteo Franceschetti, Matthew Dellavedova, Moshe Lifschitz, Scott Banister
Aug 1, 2024	Slingshot AI	$30.0M Seed	—	01 Advisors, 11, 1984 Ventures, AAF Management Ltd., AirAngels, AIX Ventures, American Express Ventures, Andreessen Horowitz, Backed VC, Basecamp Fund, Bessemer Venture Partners, Bling Capital, Brainchild, CrunchFund, E1 Ventures, Felicis Ventures, First Round Capital, Forerunner Ventures, Founder Collective, Future Shape, General Catalyst, GIT1K, Health Velocity Capital, Icebreaker.vc, Incisive Ventures, Innovation Endeavors, K2 Global, KW Angel Fund, Left Lane Capital, Lerer Hippeau, Lightspeed Venture Partners, Long Journey Ventures, Lux Capital, Maven Ventures, Original Capital, Pioneer Square Labs, sequel, Sequoia Capital, Shrug Capital, Social Capital, Solana Ventures, Soma Capital, Supernode Ventures, Swift Ventures, The House Fund, Todd and Rahul's Angel Fund, Tribe Capital, Wave Capital, What If Ventures, Y Combinator, Adeel Hussain, Anne Wojcicki, Bradley Horowitz, Brendan O'Driscoll, Chris Eyre, Cory Levy, David J. Phillips, Deborah Liu, Gokul Rajaram, Liu Jiang, Manuel Bronstein, Mario Gabriele, Markus Villig, Matteo Franceschetti, Matthew Dellavedova, Mattia Astori, Mei Z., Michael Stoppelman, Mo El-Bibany, Moshe Lifschitz, Nate Matherson, Nitay Joffe, Paul Graham, Sam Altman, Scott Banister, Siddharth Singhal, Timothy A. Springer
Aug 1, 2024	Fortera	$85.0M Series C	—	Highbury Group, Khosla Ventures, What If Ventures
Jul 1, 2024	Q Bio	$27.0M Venture Round	—	305 Ventures, Amadeus Capital Partners, FirstMark Capital, Khosla Ventures, NFX, Point72 Ventures, RX3 Growth Partners, Section 32, Valia Ventures, What If Ventures, Andy Coravos, Kevin Hart, Yumin Choi
Jun 1, 2024	Function Health	$53.0M Series A	—	Forerunner Ventures, KdT Ventures, NFX, Pioneer Fund, RX3 Growth Partners, John Legend, Kevin Hart, Mei Z., Whitney Cummings
May 1, 2024	Elegen	$35.0M Series B	—	Builders VC, Highbury Group, KdT Ventures, Sofinnova Investments, Wilbur-Ellis [Cavallo]
Feb 1, 2024	BioAge Labs	$170.0M Series D	—	F-Prime Capital Partners, Highbury Group, Johnson & Johnson Innovation, Sofinnova Investments, Third Rock Ventures, Uprising
Dec 1, 2023	Devoted Health	$180.0M Series E	—	Autism Impact Fund, CVS Health, F-Prime Capital Partners, Ulu Ventures
Oct 1, 2023	The Players' Lounge	$2.0M Seed	—	Aleph VC, Alumni Ventures, Amplify Partners, Bascom Ventures, Dimension Capital, Draper Associates, Expert Dojo, Humba Ventures, Mindful Venture Capital, Modern Venture Partners, Streamlined Ventures, Susa Ventures, Y Combinator, Alain Hanover, Charlie Songhurst, Erick Miller, Farzad Nazem, Ian McNish, Richard Cooperstein
Sep 1, 2023	Lemurian Labs	$9.0M Seed	—	Aleph VC, Alumni Ventures, Amplify Partners, Bascom Ventures, Dimension Capital, Draper Associates, Humba Ventures, Modern Venture Partners, Streamlined Ventures, Susa Ventures, Upside Partnership, Y Combinator, Alain Hanover, Charlie Songhurst, Erick Miller, Farzad Nazem, Ian McNish, Richard Cooperstein
Aug 1, 2023	Genesis Therapeutic	$200.0M Series B	—	Andreessen Horowitz, Pillar VC
Aug 1, 2023	Persefoni AI	$50.0M Series C	—	Aleph VC, Alumni Ventures, Amplify Partners, Bascom Ventures, Dimension Capital, Draper Associates, Humba Ventures, Modern Venture Partners, Streamlined Ventures, Susa Ventures, Y Combinator, Alain Hanover, Charlie Songhurst, Erick Miller, Farzad Nazem, Ian McNish, Richard Cooperstein
Jul 1, 2023	A-Alpha Bio	$22.0M Alpha Bio - Series A	—	Breakout Ventures, Madrona Ventures
May 1, 2023	Sagence AI	$22.0M Series A	—	7percent Ventures, Alumni Ventures, Kevin Colas
May 1, 2023	Redbeard Ventures	$25.0M Venture Round	—	01 Advisors, AAF Management Ltd., AirAngels, Andreessen Horowitz, Backed VC, Basecamp Fund, Brainchild, CrunchFund, Founder Collective, Incisive Ventures, KW Angel Fund, Long Journey Ventures, Menlo Ventures, Pioneer Square Labs, Shrug Capital, Supernode Ventures, Todd and Rahul's Angel Fund, Wave Capital, What If Ventures, Bradley Horowitz, Brendan O'Driscoll, Mario Gabriele, Matteo Franceschetti, Matthew Dellavedova, Moshe Lifschitz, Scott Banister
May 1, 2023	Pair Eyewear	$1.0M Series C	—	Aleph VC, Alumni Ventures, Amplify Partners, Bascom Ventures, Dimension Capital, Draper Associates, Humba Ventures, Modern Venture Partners, Streamlined Ventures, Susa Ventures, Y Combinator, Alain Hanover, Charlie Songhurst, Erick Miller, Farzad Nazem, Ian McNish, Richard Cooperstein
Jan 1, 2023	Asimov	$180.0M Series B	—	7percent Ventures, Alumni Ventures, Andreessen Horowitz, Blockchain.com Ventures, Deerfield Management, Faction VC, Galaxy Interactive, NGC Ventures, Oyster Ventures, Pillar VC, Sunset Ventures, George Godula, Julian Shapiro, Kevin Colas, Sahin Boydas
Jan 1, 2023	Levels	$7.0M Series A	—	01 Advisors, AAF Management Ltd., AirAngels, Andreessen Horowitz, AngelList, Backed VC, Basecamp Fund, Brainchild, Buckley Ventures, CrunchFund, Ali Tamaseb, Divergence Ventures, Founder Collective, Future Ventures, Greylock, Helium-3 Ventures, Incisive Ventures, KW Angel Fund, Liquid 2 Ventures, Long Journey Ventures, Pioneer Square Labs, Quiet Capital, Rivet Ventures, Scale Asia Ventures, Shrug Capital, Solana Ventures, Supernode Ventures, Todd and Rahul's Angel Fund, Unruly Capital, UpHonest Capital, Wave Capital, What If Ventures, Y Combinator, YLEM, Arash Ferdowsi, Aston Motes, Augusto Marietti, Bradley Horowitz, Brendan O'Driscoll, Dylan Field, Howie Liu, Immad Akhund, Jack Smith, Mario Gabriele, Matt Bellamy, Matteo Franceschetti, Matthew Dellavedova, Moshe Lifschitz, Paul McKellar, Scott Banister, Sumon Sadhu
Jan 1, 2023	Paradigm	$200.0M Series A	—	7wire Ventures, 8VC, Andreessen Horowitz, ARCH Venture Partners, TJ Nahigian, BoxGroup, Buckley Ventures, Byers Capital, Foresite Capital, Founders Fund, F-Prime Capital Partners, General Catalyst, Krishna Yeshwant, Human Capital, Javelin Venture Partners, LiveOak Venture Partners, Lux Capital, Mubadala, Norwest Venture Partners, Octopus Ventures, Omega Funds, Pitbull Ventures, Presight Capital, RallyCry Ventures, Gordon Wintrob, Nikhil Krishnan, Zak Kukoff
Dec 1, 2022	Vaultree	$13.0M Series A	—	01 Advisors, AAF Management Ltd., AirAngels, Andreessen Horowitz, Backed VC, Basecamp Fund, Brainchild, CrunchFund, Founder Collective, Incisive Ventures, KW Angel Fund, Long Journey Ventures, Pioneer Square Labs, Shrug Capital, Supernode Ventures, Todd and Rahul's Angel Fund, Wave Capital, What If Ventures, Bradley Horowitz, Brendan O'Driscoll, Mario Gabriele, Matteo Franceschetti, Matthew Dellavedova, Moshe Lifschitz, Scott Banister
Dec 1, 2022	lockr	$3.0M Seed	—	01 Advisors, 040 Capital, AAF Management Ltd., AirAngels, Alchemy Ventures, Alpaca VC, Andreessen Horowitz, Archetype, Backed VC, Basecamp Fund, Blockchain.com Ventures, Brainchild, CrunchFund, Matt Ocko, FJ Labs, Flashpoint VC, Founder Collective, Founders Fund, Gaingels, Grit Capital Partners, Hack VC, Incisive Ventures, Khosla Ventures, KW Angel Fund, LAUNCHub Ventures, Lavrock Ventures, Lightbank, Lightspeed Venture Partners, Long Journey Ventures, MarsBio, Mosaic Ventures, Offline Ventures, Palisades Growth Capital, Pioneer Square Labs, Play Ventures, Presight Capital, Shrug Capital, SOSV, Supernode Ventures, Tekton Ventures, Todd and Rahul's Angel Fund, Tuesday Capital, Union Square Ventures, Wave Capital, What If Ventures, Zag Capital, Ahikam Kaufman, Alex Pack, Anastasia Andrianova, Bradley Horowitz, Brendan O'Driscoll, Eric Seufert, Erik Matlick, Esther Dyson, Fernando Martinelli, Mario Gabriele, Matteo Franceschetti, Matthew Dellavedova, Moshe Lifschitz, Scott Banister, Stani Kulechov, Tim Kendall

Financial History

Total Raised

N/A

Valuation

N/A

Leadership Team

Key people at VZVC.

Vijay Pande

Managing Partner

Leadership Team

Key people at VZVC.

Vijay Pande

Managing Partner

Deep Dive

High-Level Overview

VZVC is a venture capital firm co-founded by Vijay Pande and Zack Werner, focused on investing in healthcare opportunities enabled by artificial intelligence (AI). The firm targets startups that leverage AI to solve critical problems in healthcare, aiming to transform how diseases are understood, diagnosed, and treated. VZVC’s investment philosophy centers on backing companies that use cutting-edge technology to address humanity’s biggest health challenges, particularly in areas like drug discovery, diagnostics, and care access. By concentrating on AI-driven healthcare innovation, VZVC plays a significant role in accelerating the startup ecosystem at the intersection of biotech and AI, fostering breakthroughs that could reshape medicine and patient outcomes[1][2].

Origin Story

VZVC was founded in 2025 by Vijay Pande, a former General Partner at Andreessen Horowitz and founder of its Bio + Health fund, and Zack Werner, both experienced healthcare investors. Pande’s background includes pioneering the use of machine learning in biology and chemistry, with investments in companies such as Function Health, Insitro, and Freenome. The idea for VZVC emerged from their shared vision to focus specifically on AI’s transformative potential in healthcare, building on Pande’s extensive experience in biotech investing and Werner’s healthcare expertise. The firm’s founding marks a strategic evolution from Pande’s prior work at Andreessen Horowitz to a more specialized, AI-centric healthcare investment approach[1][2][3].

Core Differentiators

Specialized Focus: Exclusive concentration on AI applications in healthcare, differentiating VZVC from broader life sciences or tech investors.
Founders’ Expertise: Led by Vijay Pande, a recognized AI and biotech pioneer with a strong track record in bio + health investing.
Deep Network: Access to top-tier scientific advisors and strategic partners, including collaborations with companies like insitro, Bristol Myers Squibb, and Eli Lilly.
Operating Support: Combines computational biology insights with traditional drug development expertise to guide portfolio companies effectively.
Strategic Vision: Emphasis on solving complex healthcare problems through AI-driven causal biology and machine learning, enabling precision medicine and novel therapeutics[1][2].

Role in the Broader Tech Landscape

VZVC is positioned at the convergence of two major trends: the rapid advancement of AI technologies and the urgent need for innovation in healthcare. The timing is critical as AI capabilities mature, regulatory environments evolve, and healthcare systems seek more efficient, personalized solutions. VZVC’s focus on AI-enabled healthcare innovation aligns with growing market forces such as increased data availability, computational power, and demand for better diagnostics and therapeutics. By investing in this niche, VZVC influences the broader ecosystem by accelerating the adoption of AI in biopharma, fostering collaborations between tech and healthcare sectors, and helping to translate computational breakthroughs into clinical impact[1][2][3].

Quick Take & Future Outlook

Looking ahead, VZVC is likely to deepen its investments in AI-driven drug discovery, diagnostics, and healthcare delivery platforms. Trends such as causal biology, multi-modal data integration, and machine learning-guided therapeutics will shape its portfolio’s evolution. As AI continues to prove its value in reducing R&D costs and improving clinical outcomes, VZVC’s influence in the biotech and healthcare startup ecosystem is expected to grow. The firm’s specialized expertise and strategic partnerships position it well to capitalize on emerging opportunities and help define the future of AI in medicine, reinforcing its role as a catalyst for transformative healthcare innovation[1][2][3].

Sources

High-Level Overview

Origin Story

Core Differentiators

Specialized Focus: Exclusive concentration on AI applications in healthcare, differentiating VZVC from broader life sciences or tech investors.
Founders’ Expertise: Led by Vijay Pande, a recognized AI and biotech pioneer with a strong track record in bio + health investing.
Deep Network: Access to top-tier scientific advisors and strategic partners, including collaborations with companies like insitro, Bristol Myers Squibb, and Eli Lilly.
Operating Support: Combines computational biology insights with traditional drug development expertise to guide portfolio companies effectively.
Strategic Vision: Emphasis on solving complex healthcare problems through AI-driven causal biology and machine learning, enabling precision medicine and novel therapeutics[1][2].